Headquartered in Birmingham, Ala., CIRCULOGENE is an innovative molecular diagnostics company founded and operated by a team of experienced industry executives and skilled molecular diagnostics scientists. Applying its proprietary laboratory developed test for cfDNA, cfRNA and MSI liquid biopsies, CIRCULOGENE has developed a next-generation sequencing (NGS) method to provide full genomic load analysis from one standard tube of blood in one week, enabling more accurate data to help clinicians and their patients choose targeted therapies, monitor efficacy and monitor for recurrence. One tube, one week, complete results. Somatic + Germline; Blood + Tissue + Buccal; DNA + RNA + MSI + PD-L1. CONTACT info@circulogene.com For Asia Pacific inquiries, please email AsiaPacfic@circulogene.com For Middle Eastern inquiries, please email Irem.Agin@circulogene.com.tr
Looking for a particular CIRCULOGENE employee's phone or email?
The CIRCULOGENE annual revenue was $2 million in 2026.
Michael Mullen is the Chairman and CEO of CIRCULOGENE.
33 people are employed at CIRCULOGENE.
CIRCULOGENE is based in Birmingham, Alabama.
The NAICS codes for CIRCULOGENE are [54171, 54, 541713, 541, 5417].
The SIC codes for CIRCULOGENE are [87, 873].